MUSC Women's Reproductive Behavioral Health Program for Opioid Use During Pregnancy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 98
- 试验地点
- 1
- 主要终点
- Percent of infants born with Neonatal Abstinence Syndrome (NAS)
研究概览
简要总结
To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.
详细描述
Participants: Pregnant women with OUD.
Intervention: Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine.
Design: A cohort derived from a prospectively collected database including 98 women receiving perinatal OUD treatment in an obstetric practice by telemedicine or in-person and followed until 6-8 weeks postpartum from September, 2017 to December, 2018. Logistic regression with propensity score adjustment was applied to reduce group selection bias and control for potentially confounding variables.
Setting: Four outpatient obstetric practices in the southeast.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Adult females, any race or ethnicity, age 18-45 years
- •Currently pregnant
- •Opioid Use Disorder (OUD)
- •received in person or telemedicine treatment for OUD in their obstetrician's office
排除标准
- •Not currently pregnant or receiving perinatal care
- •Not in agreement with Patient-Physician Agreement
结局指标
主要结局
Percent of infants born with Neonatal Abstinence Syndrome (NAS)
时间窗: At Delivery
Newborn withdrawal, also know as NAS gathered via electronic health record
Number of individuals retained in treatment
时间窗: 6-8 weeks postpartum
Uninterrupted addiction treatment during pregnancy through 6-8 weeks postpartum
次要结局
- Positive urine drug screens(At delivery and 6-8 weeks postpartum)
- Length of newborn hospital stay and birth weight(Assessed up to 6 months following delivery)